GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis

Carcinogenesis

Volumn 32, Issue 2, 2011, Pages 182-189

  Moore, L E ^a   Baris, D R ^a   Figueroa, J D ^a   Garcia Closas, M ^a   Karagas, M R ^b   Schwenn, M R ^c   Johnson, A T ^d   Lubin, J H ^a   Hein, D W ^e   Dagnall, C L ^a,f   Colt, J S ^a   Kida, M ^g   Jones, M A ^h   Schned, A R ^b   Cherala, S S ⁱ   Chanock, S J ^a   Cantor, K P ^a   Silverman, D T ^a   Rothman, N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c Maine Center for Disease Control   (United States)

^d Vermont Cancer Registry   (United States)

^e University of Louisville School of Medicine   (United States)

^f SAIC FREDERICK INC   (United States)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^h Southern Maine Medical Center   (United States)

ⁱ New Hampshire Environmental Department of Health and Human Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ACETYLATION; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

EID: 79251542378     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq223     Document Type: Article

References (27)

1. Garcia-Closas,M. et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366, 649-659.
2. Lubin,J.H. et al. (2007) Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Int. J. Epidemiol., 36, 236-241.
3. Rothman,N. et al. (2007) Commentary: reflections on G.M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned. Int. J. Epidemiol., 36, 23-28.
4. Baris,D. et al. (2009) A case-control study of smoking and bladder cancer risk: emergent patterns over time. J. Natl Cancer Inst., 101, 1553-1561.
5. Hein,D.W. et al. (2000) Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics, 10, 291-292.
6. Arylamine N-acetyltransferase nomenclature committee. Arylamine NAcetyltransferase (NAT) Nomenclature. www.louisville.edu/medschool/pharmacology/NAT.html. (30 November 2010, date last accessed).
7. Laird,N.M. et al. (1990) Some statistical methods for combining experimental results. Int. J. Technol. Assess. Health Care, 6, 5-30.
8. Higgins,J.P.T. et al. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.
9. Harbord,R.M. et al. (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat. Med., 25, 3443-3457.
10. Begg,C.B. et al. (1994) Statistical-analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol. Biomarkers Prev., 3, 173-175.
11. Piegorsch,W.W. et al. (1994) Non-hierarchical logistic-models and caseonly designs for assessing susceptibility in population-based case-control studies. Stat. Med., 13, 153-162.
12. Taylor,J.A. et al. (1998) The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res., 58, 3603-3610.
13. Gu,J. et al. (2005) Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat. Res., 581, 97-104.
14. Yuan,J.M. et al. (2008) Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis, 29, 1386-1393.
15. Rouissi,K. et al. (2009) Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet. Cytogenet., 190, 101-107.
16. Song,D.K. et al. (2009) Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect. Prev., 32, 416-423.
17. Lu,C.M. et al. (2005) Interaction effect in bladder cancer between Nacetyltransferase 2 genotype and alcohol drinking. Urol. Int., 75, 360-364.
18. Zhao,H. et al. (2007) Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int. J. Cancer., 120, 2208-2213.
19. McGrath,M. et al. (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer, 6, 239.
20. Kellen,E. et al. (2007) Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?: The Belgian case control study on bladder cancer risk. Cancer Lett., 245, 51-60.
21. Fontana,L. et al. (2009) Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French Cohort. Anticancer Res., 29, 1631-1635.
22. Zupa,A. et al. (2009) GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer Res., 29, 1709-1714.
23. Silverman,D. et al. (2006) Bladder cancer. In Schottenfeld,D., Fraumeni,J. (eds.) Cancer Epidemiology and Prevention. Oxford University Press, New York, NY.
24. Vineis,P. et al. (1988) Effects of timing and type of tobacco in cigaretteinduced bladder-cancer. Cancer Res., 48, 3849-3852.
25. Taioli,E. (2008) Gene-environment interaction in tobacco-related cancers. Carcinogenesis, 29, 1467-1474.
26. Dusinska,M. et al. (2001) Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat. Res., 482, 47-55.
27. Breton,C.V. et al. (2007) GSTM1 and APE1 genotypes affect arsenicinduced oxidative stress: a repeated measures study. Environ. Health., 6, 39.